Works matching IS 11732563 AND DT 2020 AND VI 40 AND IP 2
Results: 9
Pharmacokinetics and Bioequivalence Evaluation of a New Oxycodone Tamper-Resistant Tablet Administered with an Opioid Antagonist in Patients with Chronic Pain.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 139, doi. 10.1007/s40261-019-00870-w
- By:
- Publication type:
- Article
Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 129, doi. 10.1007/s40261-019-00869-3
- By:
- Publication type:
- Article
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects with Normal and Impaired Renal Function.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 149, doi. 10.1007/s40261-019-00873-7
- By:
- Publication type:
- Article
PCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world Study.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 173, doi. 10.1007/s40261-019-00877-3
- By:
- Publication type:
- Article
Cost Effectiveness of Ceritinib and Alectinib Versus Crizotinib in First-Line Anaplastic Lymphoma Kinase-Positive Advanced Non-small-cell Lung Cancer.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 183, doi. 10.1007/s40261-019-00880-8
- By:
- Publication type:
- Article
A Caprini Risk Score-Based Cost-Effectiveness Analysis of Enoxaparin for the Thromboprophylaxis of Patients After Nonorthopedic Surgery in a Chinese Healthcare Setting.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 161, doi. 10.1007/s40261-019-00876-4
- By:
- Publication type:
- Article
Bleeding Risk of Therapeutic Unfractionated Heparin and Low Molecular Weight Heparin in Patients with Cirrhosis.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 191, doi. 10.1007/s40261-019-00875-5
- By:
- Publication type:
- Article
Early and Late Switch from Ranibizumab to an Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema in the Event of a Poor Anatomical Response.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 119, doi. 10.1007/s40261-019-00865-7
- By:
- Publication type:
- Article
Safety, Tolerability, and Effects of Sodium Bicarbonate Inhalation in Cystic Fibrosis.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 2, p. 105, doi. 10.1007/s40261-019-00861-x
- By:
- Publication type:
- Article